Have your own idea? Try our Stock Screener
UPDATED Nov 28, 2024
Discover large cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
JTBK | US$0.0029 | 0% | -34.1% | US$798.7k | n/a | n/a | n/a | n/a | ||
531521 | ₹15.04 | 0% | 127.2% | ₹66.8m | n/a | PE12.5x | n/a | n/a | ||
KAYS | US$0.035 | 14.5% | -16.5% | US$787.1k | n/a | PS12.1x | n/a | n/a | ||
UNVO | ₪0.093 | 0% | -94.3% | ₪2.8m | n/a | PB0.2x | n/a | n/a | ||
GPFT | US$0.0007 | 0% | -61.1% | US$774.7k | n/a | n/a | n/a | n/a | ||
ITMC | US$0.0018 | 0% | -73.3% | US$770.8k | n/a | n/a | n/a | n/a | ||
WAVE | CA$0.02 | 33.3% | n/a | CA$1.1m | n/a | PS15.2x | n/a | n/a | ||
PBM | US$3.46 | 6.1% | -99.6% | US$770.3k | n/a | PE-0.02x | n/a | n/a | ||
SPRC | US$0.21 | -12.7% | -97.3% | US$768.3k | n/a | PB0.1x | E63.0% | n/a | ||
ACCR | US$0.0017 | 112.5% | 41.7% | US$767.6k | n/a | n/a | n/a | n/a | ||
LSMG | US$0.0063 | 0% | n/a | US$761.9k | n/a | PE-13.4x | n/a | n/a | ||
ISCO | US$0.093 | -22.2% | -16.7% | US$747.2k | n/a | PE-1.4x | n/a | n/a | ||
GV | €0.0018 | 0% | -91.3% | €692.9k | n/a | PE-0.07x | n/a | n/a | ||
HEAL | CA$0.035 | -12.5% | -72.0% | CA$1.0m | n/a | PE-1.7x | n/a | n/a | ||
SQZB | US$0.025 | -10.7% | 6.8% | US$737.3k | n/a | PB0.4x | n/a | n/a | ||
531240 | ₹11.30 | -3.3% | 76.6% | ₹61.3m | n/a | PB3.7x | n/a | n/a | ||
NPHC | US$0.0001 | 0% | 9,900.0% | US$710.0k | n/a | n/a | n/a | n/a | ||
MAGNA | SEK 0.12 | -6.6% | -87.3% | SEK 7.6m | n/a | PE-0.2x | n/a | n/a | ||
CLAS.H | CA$0.025 | 0% | n/a | CA$944.7k | n/a | n/a | n/a | n/a | ||
PROGEN | SEK 7.50 | -8.5% | -89.6% | SEK 7.4m | n/a | PS1.8x | n/a | n/a | ||
CFRX | US$0.069 | 14.2% | -99.4% | US$676.1k | US$7.00 | PE-0.03x | n/a | n/a | ||
BLPH | US$0.055 | 0% | 54.9% | US$672.8k | n/a | PB0.2x | n/a | n/a | ||
NOUV | US$0.0001 | 9,900.0% | -50.0% | US$666.1k | n/a | n/a | n/a | n/a | ||
RSPI | US$0.0007 | -12.5% | -48.1% | US$664.6k | n/a | PE-0.3x | n/a | n/a |